Mucuna pruriens seed

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Mucuna pruriens seed
DrugBank Accession Number
DB14299
Background

Mucuna pruriens seed is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental
Synonyms
  • Atmagupta Seed
  • Buffalo Bean Seed
  • Carpopogon Atropurpureum Seed
  • Cowage Seed
  • Cowitch Seed
  • Dolichos Pruriens Seed
  • Kapikacchu Seed
  • Mucuna Atropurpurea Seed
  • Mucuna Axillaris Seed
  • Mucuna Bernieriana Seed
  • Mucuna Cochinchinensis Seed
  • Mucuna Esquirolii Seed
  • Mucuna Minima Seed
  • Mucuna Nivea Seed
  • Mucuna Pruriens Seed Extract
  • Mucuna Prurita Seed
  • Stizolobium Pruritum Seed
  • Velvet Bean Seed

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
EdgeMucuna pruriens seed (.025 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Gambir (2 mg/1g) + Ginkgo biloba (.124 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalAloe Vera Industries Pty Ltd2015-04-01Not applicableUS flag
EdgeMucuna pruriens seed (.025 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Gambir (2 mg/1g) + Ginkgo biloba (.124 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalSensuous Pty Ltd2015-04-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
EdgeMucuna pruriens seed (.025 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Gambir (2 mg/1g) + Ginkgo biloba (.124 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalAloe Vera Industries Pty Ltd2015-04-01Not applicableUS flag
EdgeMucuna pruriens seed (.025 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Gambir (2 mg/1g) + Ginkgo biloba (.124 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalSensuous Pty Ltd2015-04-01Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
55G8SQ543S
CAS number
Not Available

References

General References
Not Available
RxNav
1485786

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53